Evidence map›Paper›PMID 38238585›Full record

ArticleInternational journal of behavioral medicine2024

Moderators of Loneliness Trajectories in People with Systemic Sclerosis During the COVID-19 Pandemic: A SPIN COVID-19 Cohort Longitudinal Study.

Chelsea S Rapoport, Alyssa K Choi, Linda Kwakkenbos, Marie-Eve Carrier, Richard S Henry, Brooke Levis, Susan J Bartlett, Amy Gietzen, Karen Gottesman, Geneviève Guillot and 11 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in International journal of behavioral medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 4 countries.

Chelsea S RapoportSDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA.
Alyssa K ChoiSDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA.
Linda KwakkenbosDepartment of Clinical Psychology, Radboud University, Nijmegen, the Netherlands.
Marie-Eve CarrierLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Richard S HenryLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Brooke LevisLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Susan J BartlettDepartment of Medicine, McGill University, Montreal, QC, Canada.
Amy GietzenNational Scleroderma Foundation, Tri-State Chapter, Buffalo, NY, USA.
Karen GottesmanNational Scleroderma Foundation, Los Angeles, CA, USA.
Geneviève GuillotSclérodermie Québec, Longueuil, QC, Canada.
Amanda Lawrie-JonesScleroderma Australia, Melbourne, VIC, Australia.
Maureen D MayesDepartment of Internal Medicine, University of Texas McGovern School of Medicine, Houston, TX, USA.
Luc MouthonService de Médecine Interne, Centre de Référence Maladies Autoimmunes Systémiques Rares d'Ile de France, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
Michelle RichardScleroderma Atlantic, Halifax, NS, Canada.
Maureen Worron-SauvéScleroderma Society of Ontario, Hamilton, ON, Canada.
Andrea BenedettiDepartment of Medicine, McGill University, Montreal, QC, Canada.
Scott C RoeschSDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA.
Brett D ThombsLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Vanessa L MalcarneSDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA. vmalcarne@sdsu.edu.ORCID http://orcid.org/0000-0002-7526-9982
SPIN COVID-19 Patient Advisory Team
SPIN Investigators
Jewish General Hospital · CASan Diego State University · USScleroderma Foundation · USMcGill University Health Centre · CAMultiple Sclerosis Society of Canada · CAHôpital Cochin · FRRadboud University Nijmegen · NL

Funding

CIHR Postdoctoral FellowshipCIHR VR4-172745, GA4-177764McGill University Mi4 Interdisciplinary Initiative in Infection and Immunity Emergency COVID-19 Research FundNational Science Foundation 1842470
6 · The paper itself

Abstract

backgroundMany individuals with systemic sclerosis (SSc) are at heightened risk for COVID-19 related morbidity and isolation due to interstitial lung disease, frailty, and immunosuppressant use. Minimal research has explored loneliness predictors in individuals with chronic illnesses during COVID-19. This study evaluated moderators of loneliness trajectories in individuals with SSc during COVID-19.

methodsLongitudinal data were analyzed across 30 timepoints from April 2020 to May 2022 from 775 adults in the Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 Cohort. Hierarchical linear modeling evaluated cross-level moderators of loneliness trajectories, including marital status, baseline number of household members, number of virtual or telephone one-on-one or virtual group conversations, number of hours spent enjoying in-person household conversations or activities, and satisfaction with quality of in-person household conversations (all in the past week). Level-1 moderation analyses assessed effects of conversation, activity, and satisfaction means and slopes over time.

resultsBaseline values were not statistically significant moderators of loneliness trajectories. Higher mean (averaged over time) virtual or telephone one-on-one and in-person household conversations, in-person household activity, and in-person household conversation satisfaction were associated with lower loneliness trajectories (ps < .05). The relationship between in-person household conversation satisfaction and loneliness trajectory was statistically significantly but minimally attenuated over time (p < .001).

conclusionsFor people with SSc, higher mean conversation, activity, and satisfaction variables were associated with lower levels of loneliness during the pandemic, but changes in these social variables were generally not predictive of changes in loneliness.

Indexed as

COVID-19LonelinessScleroderma, SystemicAdultAgedCohort StudiesFemaleHumansLongitudinal StudiesMaleMiddle AgedPersonal SatisfactionCOVID-19LonelinessSclerodermaSocial supportSystemic sclerosis

Identifiers

PMID38238585
OpenAlexW4390964743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.